Financial Performance - The company's operating revenue for Q3 2021 reached ¥2,432,855,803.76, representing a year-on-year increase of 24.09%[7] - Net profit attributable to shareholders was ¥240,975,500.05, up 58.43% compared to the same period last year[7] - The net profit excluding non-recurring gains and losses was ¥234,512,586.55, reflecting a 62.90% increase year-on-year[7] - Basic and diluted earnings per share were both ¥0.125, an increase of 58.43% from the previous year[10] - The weighted average return on equity rose to 3.81%, an increase of 1.32 percentage points compared to the same period last year[10] - The net profit attributable to shareholders for the first three quarters of 2021 was ¥1,704,523,426.45, compared to ¥1,176,450,331.88 in the same period of 2020, reflecting a 45% increase[31] - The net profit for the current period reached CNY 720,671,695.65, a significant increase from CNY 363,673,041.24 in the previous period, representing a growth of approximately 98.3%[38] - The total profit amounted to CNY 836,193,451.00, compared to CNY 415,646,026.19 in the same period last year, indicating an increase of about 101.0%[38] - The operating profit for the current period was CNY 849,235,393.62, up from CNY 428,063,838.12, reflecting a growth of approximately 98.3%[38] - Basic earnings per share for the current period were CNY 0.37, compared to CNY 0.19 in the previous period, representing an increase of approximately 94.7%[40] Revenue and Sales - The total revenue from the main business reached ¥5,995,406,176.68, with a gross margin of 22.70%, reflecting a 38.92% increase in revenue year-on-year[19] - Domestic sales accounted for ¥4,927,910,435.49 in revenue, with a gross margin of 25.58%, and a year-on-year revenue increase of 32.61%[22] - The export revenue was ¥1,067,495,741.19, with a gross margin of 9.37%, and a significant year-on-year revenue increase of 78.04%[22] - The revenue from polyvinyl alcohol (PVA) was ¥1,925,482,160.68, with a gross margin of 32.73%, and a year-on-year revenue increase of 21.02%[21] - The chemical industry generated revenue of ¥4,792,372,684.01 with a gross margin of 21.96%, showing a year-on-year revenue increase of 44.97%[19] Costs and Expenses - The company reported a total operating cost of ¥4,634,649,323.44, reflecting a year-on-year increase of 31.28%[22] - Total operating costs for the third quarter of 2021 were ¥5,389,853,919.48, up from ¥4,259,800,852.58 in the third quarter of 2020, reflecting a 26.5% increase[35] - Research and development expenses for the third quarter of 2021 amounted to ¥239,432,396.11, compared to ¥195,851,471.48 in the same period of 2020, indicating a 22.2% increase[35] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,513,985,384.58, a 7.52% increase from the end of the previous year[10] - The company's total assets as of September 30, 2021, were ¥11,513,985,384.58, an increase from ¥10,708,467,077.35 at the end of 2020[29] - Current assets totaled ¥4,589,273,325.34 as of September 30, 2021, compared to ¥3,932,530,030.59 at the end of 2020, representing a 16.6% increase[29] - The company's total liabilities as of September 30, 2021, were ¥5,402,298,424.13, up from ¥5,019,052,114.18 at the end of 2020[31] - The company reported a total liability of approximately ¥5.02 billion, with current liabilities at ¥3.71 billion and non-current liabilities at ¥1.31 billion[55] Shareholder Information - The total number of common shareholders at the end of the reporting period is 77,880[16] - Anhui Wanwei Group Co., Ltd. holds 591,965,118 shares, accounting for 30.74% of total shares, with 235,000,000 shares pledged[16] - The company's equity attributable to shareholders increased to ¥6,075,633,490.08 as of September 30, 2021, compared to ¥5,674,370,624.68 at the end of 2020, marking a 7.1% increase[31] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥1,449,823,157.43, showing a 43.66% increase year-on-year[10] - The cash flow from operating activities generated a net amount of CNY 1,449,823,157.43, compared to CNY 1,009,224,071.94 in the previous year, marking an increase of about 43.7%[44] - The company reported cash inflows from operating activities totaling CNY 5,208,310,935.45, compared to CNY 4,098,439,744.52 in the previous year, reflecting an increase of approximately 27.1%[44] - The company incurred cash outflows from investing activities of CNY 817,487,244.72, down from CNY 1,742,289,986.85 in the previous period, indicating a decrease of about 53.0%[46] - The net cash flow from financing activities was negative at CNY -676,994,536.49, compared to a positive CNY 583,003,123.50 in the previous period, showing a significant change in financing strategy[46] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to sustain growth[12] - The company is focused on expanding its market presence and enhancing product development strategies[19] - Future outlook remains positive, with strategic plans for market expansion and potential acquisitions[54] Other Information - The company has ongoing research and development efforts, although specific new products or technologies were not detailed in the report[54] - The company has fixed assets valued at approximately ¥4.07 billion, with a decrease of ¥172.14 million due to reclassification of assets[50] - The company has long-term investments in equity instruments amounting to approximately ¥1.14 billion[50] - The company has a deferred tax asset of approximately ¥59.47 million, indicating potential future tax benefits[52] - Cash and cash equivalents stood at approximately ¥1.88 billion, indicating strong liquidity position[50] - Cash and cash equivalents at the end of the period totaled CNY 234,908,096.01, up from CNY 122,586,008.64 at the end of the previous period, indicating a growth of about 91.5%[46]
皖维高新(600063) - 2021 Q3 - 季度财报